1.3199
-0.05 (-3.65%)
-0.05 (-3.65%)
Upgrade to Real-Time
Afterhours
Volume | 32,486 |
|
|||||
News | - | ||||||
Day High | 1.40 | Low High |
|||||
Day Low | 1.3101 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Reunion Neuroscience Inc | REUN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.40 | 1.3101 | 1.40 | 1.38 | 1.3699 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
217 | 32,486 | $ 1.37 | $ 44,379 | - | 0.7625 - 7.62 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:02:47 | 7 | $ 1.33 | USD |
Reunion Neuroscience Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 15.37M | 11.64M | 7.60M | $ 3.89M | $ - | -3.80 | -0.30 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | - | - |
Reunion Neuroscience News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REUN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.43 | 1.49 | 1.24 | 1.34 | 38,648 | -0.1101 | -7.7% |
1 Month | 0.7625 | 1.59 | 0.7625 | 1.40 | 94,923 | 0.5574 | 73.1% |
3 Months | 1.59 | 1.66 | 0.7625 | 1.36 | 38,424 | -0.2701 | -16.99% |
6 Months | 3.79 | 7.62 | 0.7625 | 2.77 | 52,378 | -2.47 | -65.17% |
1 Year | 3.79 | 7.62 | 0.7625 | 2.77 | 52,378 | -2.47 | -65.17% |
3 Years | 3.79 | 7.62 | 0.7625 | 2.77 | 52,378 | -2.47 | -65.17% |
5 Years | 3.79 | 7.62 | 0.7625 | 2.77 | 52,378 | -2.47 | -65.17% |
Reunion Neuroscience Description
Field Trip is a global leader in the development and delivery of psychedelic therapies. With Field Trip Discovery, the company's research division, leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics, and its Field Trip Health division building centers for psychedelic therapies across North America and Europe along with the digital and technological tools that will enable massive scale. |